Skip to main content
Journal of Asthma and Allergy logoLink to Journal of Asthma and Allergy
. 2023 Sep 27;16:1053–1054. doi: 10.2147/JAA.S441410

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]

PMCID: PMC10543922  PMID: 37791042

Laidlaw TM, Menzies-Gow A, Caveney S, et al. J Asthma Allergy. 2023;16:915–932.

The authors have advised there is an error in Figure 1 on page 922. The n= x-axis data were transposed for the treatment groups for both the Patients with NPs and Patients without NPs. The correct Figure 1 is as follows.

Figure 1.

Figure 1

AAER over 52 weeks in patients with or without nasal polyps in the 2 years before randomization in the NAVIGATOR study.

Note: n, number of patients contributing to the analysis.

Abbreviations: AAER, annualized asthma exacerbation rate; CI, confidence interval; NP, nasal polyp; Q4W, every 4 weeks.

The authors apologize for this error.


Articles from Journal of Asthma and Allergy are provided here courtesy of Dove Press

RESOURCES